Genpact (G) Posts Earnings Results, Beats Expectations By $0.02 EPS
Genpact (NYSE:G) issued its quarterly earnings results on Monday. The business services provider reported $0.43 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.02, Bloomberg Earnings reports. The firm had revenue of $734.41 million for the quarter, compared to analyst estimates of $723.55 million. Genpact had a return on equity of 23.53% and a net margin of 9.61%. The business’s revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.43 earnings per share. Genpact updated its FY18 guidance to $1.70-1.74 EPS.
Genpact (NYSE:G) opened at $30.32 on Wednesday. The firm has a market capitalization of $6,235.27, a price-to-earnings ratio of 21.39, a price-to-earnings-growth ratio of 2.01 and a beta of 0.57. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.65 and a current ratio of 1.65. Genpact has a 12 month low of $23.34 and a 12 month high of $34.79.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 21st. Shareholders of record on Friday, March 9th will be paid a dividend of $0.075 per share. The ex-dividend date is Thursday, March 8th. This represents a $0.30 dividend on an annualized basis and a yield of 0.99%. This is a positive change from Genpact’s previous quarterly dividend of $0.06. Genpact’s payout ratio is 17.91%.
In other news, SVP Arvinder Singh sold 22,855 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $32.23, for a total value of $736,616.65. Following the transaction, the senior vice president now owns 37,623 shares of the company’s stock, valued at approximately $1,212,589.29. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Piyush Mehta sold 12,500 shares of the company’s stock in a transaction on Monday, November 27th. The shares were sold at an average price of $32.00, for a total value of $400,000.00. Following the completion of the transaction, the senior vice president now directly owns 77,944 shares in the company, valued at approximately $2,494,208. The disclosure for this sale can be found here. Insiders have sold 1,660,470 shares of company stock worth $50,598,982 in the last three months. 1.41% of the stock is currently owned by corporate insiders.
An institutional investor recently raised its position in Genpact stock. The Manufacturers Life Insurance Company grew its holdings in Genpact Limited (NYSE:G) by 7.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,508 shares of the business services provider’s stock after purchasing an additional 455 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Genpact were worth $181,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 92.00% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at https://theolympiareport.com/2018/02/14/genpact-g-posts-earnings-results-beats-expectations-by-0-02-eps.html.
Genpact Company Profile
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.